Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society
|
December 23, 2023
Evaluation of mediastinal lymph node segmentation of heterogeneous CT data with full and weak supervision
Alireza Mehrtash, Erik Ziegler, Tagwa Idris, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 4, 2025
Effect of bone marrow disease on hematologic toxicity and response to [<sup>177</sup>Lu]Lu-PSMA-617 therapy: insights from PSMA-PET/CT imaging
Nuno Borges, Meryam Losee, Mofei Liu, et al.
JCO Oncology Practice
|
April 24, 2026
Efficacy and Safety of 177Lu-PSMA-617 in Elderly Patients With Metastatic Castration-Resistant Prostate Cancer
Daniel Sentana-Lledo, Avina Rami, Caiwei Zhong, et al.
American Journal of Clinical Oncology
|
June 21, 2021
Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer
Kelly A Hirko, Meredith M Regan, Marie C Remolano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2022
Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers?
Maha Hussain, Michael A Carducci, Noel Clarke, et al.
Clinical Colorectal Cancer
|
January 7, 2011
Phase I trial of oxaliplatin, infusional 5-fluorouracil, and leucovorin (FOLFOX4) with erlotinib and bevacizumab in colorectal cancer
Wells A Messersmith, Antonio Jimeno, Heather Jacene, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2023
SNMMI Consensus Statement on Patient Selection and Appropriate Use of
Thomas A Hope, Emmanuel S Antonarakis, Lisa Bodei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 16, 2026
LASER: A Phase 2 Trial of <sup>177</sup>Lu-PSMA-617 as Systemic Therapy for RCC
Shir Hazut Krauthammer, Wanling Xie, Nicole LaBrecque, et al.
Endocrine-Related Cancer
|
June 22, 2022
SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma
Kimberly Perez, Heather Jacene, Jason L Hornick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 26, 2023
Clinical Implementation of <sup>177</sup>Lu-PSMA-617 in the United States: Lessons Learned and Ongoing Challenges
Praful Ravi, Bridget Whelpley, Emma Kelly, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society
|
December 23, 2023
Evaluation of mediastinal lymph node segmentation of heterogeneous CT data with full and weak supervision
Alireza Mehrtash, Erik Ziegler, Tagwa Idris, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 4, 2025
Effect of bone marrow disease on hematologic toxicity and response to [<sup>177</sup>Lu]Lu-PSMA-617 therapy: insights from PSMA-PET/CT imaging
Nuno Borges, Meryam Losee, Mofei Liu, et al.
JCO Oncology Practice
|
April 24, 2026
Efficacy and Safety of 177Lu-PSMA-617 in Elderly Patients With Metastatic Castration-Resistant Prostate Cancer
Daniel Sentana-Lledo, Avina Rami, Caiwei Zhong, et al.
American Journal of Clinical Oncology
|
June 21, 2021
Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer
Kelly A Hirko, Meredith M Regan, Marie C Remolano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2022
Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers?
Maha Hussain, Michael A Carducci, Noel Clarke, et al.
Clinical Colorectal Cancer
|
January 7, 2011
Phase I trial of oxaliplatin, infusional 5-fluorouracil, and leucovorin (FOLFOX4) with erlotinib and bevacizumab in colorectal cancer
Wells A Messersmith, Antonio Jimeno, Heather Jacene, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2023
SNMMI Consensus Statement on Patient Selection and Appropriate Use of
Thomas A Hope, Emmanuel S Antonarakis, Lisa Bodei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 16, 2026
LASER: A Phase 2 Trial of <sup>177</sup>Lu-PSMA-617 as Systemic Therapy for RCC
Shir Hazut Krauthammer, Wanling Xie, Nicole LaBrecque, et al.
Endocrine-Related Cancer
|
June 22, 2022
SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma
Kimberly Perez, Heather Jacene, Jason L Hornick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 26, 2023
Clinical Implementation of <sup>177</sup>Lu-PSMA-617 in the United States: Lessons Learned and Ongoing Challenges
Praful Ravi, Bridget Whelpley, Emma Kelly, et al.
Page
of 7